EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Oral HPV Dynamics in MSM Living with HIV in the Nine-Valent HPV Vaccination Era

Verdiana Zulian iD, Martina De Sanctis iD, Silvia Pauciullo iD, Roberta Sciamanna, Paola Del Porto, Anna Rosa Garbuglia iD

Vaccines · 01.07.2026 · 14 (7) · 589

DOI: 10.3390/vaccines14070589 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 01.07.2026. Verfasst von Verdiana Zulian und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Oral human papillomavirus (HPV) infection is emerging as a key driver of HPV-associated oropharyngeal cancer, especially in high-risk groups such as men who have sex with men (MSM) living with HIV (PLWH). However, evidence on oral HPV persistence and the impact of nine-valent HPV vaccination in adults remains limited. We conducted a prospective longitudinal study including 76 MSM PLWH, of whom 64 were nine-valent HPV-vaccinated and 12 unvaccinated.

Methods

Oral rinse samples were collected at baseline (T0) and after 6 months (T6). HPV DNA detection and genotyping were performed using the Allplex™ HPV28 assay. Oral HPV dynamics (persistence, clearance, and incidence) were assessed for high-risk (HR) HPV, low-risk (LR) HPV, and vaccine-type HPV genotypes.

Results

Baseline oral HPV prevalence was high (59.2%), with HR HPV detected in 43.4% of participants. HPV16 was the most frequent genotype at both T0 and T6. Among participants HPV-positive at baseline, persistence of HPV DNA was high and similar regardless of vaccination status (77.8%). However, incident vaccine-type oral HPV infection was significantly lower among vaccinated individuals than unvaccinated participants (6.3% vs. 33.3%; OR 0.13, 95% CI: 0.03–0.71; p = 0.0441). Finally, reporting ≥10 sexual partners in the previous year was significantly associated with baseline oral HPV positivity (p = 0.0298).

Conclusions

In MSM PLWH, oral HPV infection is highly prevalent and persistent, underscoring that it may represent a reservoir for HPV-related oropharyngeal disease. In our small observational cohort, nine-valent HPV vaccination was associated with lower incident detection of vaccine-type oral HPV, supporting targeted vaccination and oral HPV surveillance in high-risk adult populations, while highlighting the need for larger longitudinal studies to confirm these findings and better define the magnitude and durability of vaccine-associated protection at the oral site.

Schlagwörter

Stichwörter der Autor:innen

HPV16MSMPLWHhuman papillomavirusnine-valentvaccineviral persistence

Autor:innen und Institutionen

  • Laboratory of Virology, National Institute for Infectious Diseases "Lazzaro Spallanzani" (IRCCS), 00149 Rome, Italy.
  • Department of Biology and Biotechnology "Charles Darwin", Sapienza University of Rome, 00100 Rome, Italy.

ORCID-Profile: Verdiana Zulian, Martina De Sanctis, Silvia Pauciullo, Anna Rosa Garbuglia

Förderung

  • Ministero della Salute

Zitieren

APA

Zulian, V., Sanctis, M., Pauciullo, S., Sciamanna, R., Del Porto, P., & Garbuglia, A. R. (2026). Oral HPV Dynamics in MSM Living with HIV in the Nine-Valent HPV Vaccination Era. Vaccines, 14(7), 589. https://doi.org/10.3390/vaccines14070589

Vancouver

Zulian V, Sanctis M, Pauciullo S, Sciamanna R, Del Porto P, Garbuglia AR. Oral HPV Dynamics in MSM Living with HIV in the Nine-Valent HPV Vaccination Era. Vaccines. 2026;14(7):589. doi:10.3390/vaccines14070589

BibTeX
@article{Zulian2026,
  author = {Zulian, Verdiana and Sanctis, Martina De and Pauciullo, Silvia and Sciamanna, Roberta and Del Porto, Paola and Garbuglia, Anna Rosa},
  title = {Oral HPV Dynamics in MSM Living with HIV in the Nine-Valent HPV Vaccination Era},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {7},
  pages = {589},
  doi = {10.3390/vaccines14070589}
}
Kostenlos starten →